Description
Gusacitinib is a dual inhibitor of SYK/JAK kinases.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Gusacitinib is a dual inhibitor of SYK/JAK kinases.
| Cas No. | 1425381-60-7 |
|---|---|
| Purity | ≥98% |
| Formula | C24H28N8O2 |
| Formula Wt. | 460.54 |
| IUPAC Name | 2-[1-[4-[4-(4-hydroxypiperidin-1-yl)anilino]-5-oxo-6H-pyrimido[4,5-d]pyridazin-2-yl]piperidin-4-yl]acetonitrile |
| Synonym | ASN-002, ASN002 |
| Appearance | Yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Montilla A, Gomez-Garcia F, Gomez-Arias P, et al. Scoping review on the use of drugs targeting JAK/STAT pathway in atopic dermatitis, vitiligo, and alopecia areata. Dermatol The (Heidelb). 2019 Dec;9(4):655-683. PMID: 31606872
Ca2+ ATPase and ATP-sensitive K+ channel activa...
MEK1 inhibitor.
Targets nuclear factor kappa B activation.
SHP2 inhibitor
Peptide fragment of HIV-1 gp120.
Cyclohexanecarboxylic acid found in various pla...
Flavonoid found in Epimedium.
Oxazolidone derivative; Factor Xa inhibitor.
Cdc42 GTPase inhibitor.
Endogenous peptide, involved in immune signalin...
Resveratrol prodrug; potential SIRT1 activator....
Piroxicam prodrug, NSAID; COX-1/2 inhibitor.
β2-adrenergic agonist.
Alkaloid originally found in species of Nicotia...
CDK inhibitor.
Insect sterilizer; mutagenic.
Viral M2 proton channel blocker, MAO-A, NET, NM...
NSAID; TREK1 K+ potentiator, voltage-gated Na+ ...
Voltage-gated Na+ channel blocker, mAChR antago...
Spirodihydrobenzofuranlactam